In Feb 2024, BioTroy obtained two important qualifications from Shanghai Municipal Commission of Economy and Information Technology.
This title was awarded annually to enterprises that use specialized and sophisticated technologies to produce novel and unique products, and BioTroy won this award by its originality and leading ability in new tumor treatment targets and drugs.
This title was awarded annually to enterprises with high level of professional R&D capability, strong innovation ability and great potential for development.
